0001638599-17-001155.txt : 20171120
0001638599-17-001155.hdr.sgml : 20171120
20171120160958
ACCESSION NUMBER: 0001638599-17-001155
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171117
FILED AS OF DATE: 20171120
DATE AS OF CHANGE: 20171120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smolinski Stephen
CENTRAL INDEX KEY: 0001721031
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37798
FILM NUMBER: 171213854
MAIL ADDRESS:
STREET 1: C/O SELECTA BIOSCIENCES, INC.
STREET 2: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SELECTA BIOSCIENCES INC
CENTRAL INDEX KEY: 0001453687
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-923-1400
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4_5082.xml
PRIMARY DOCUMENT
X0306
4
2017-11-17
0
0001453687
SELECTA BIOSCIENCES INC
SELB
0001721031
Smolinski Stephen
C/O SELECTA BIOSCIENCES, INC.
480 ARSENAL WAY
WATERTOWN
MA
02472
0
1
0
0
Chief Commercial Officer
Stock Option (right to buy)
10.23
2017-11-17
4
A
0
80000
0
A
2027-11-16
Common Stock
80000
80000
D
This option vests as to 25% of the shares on October 26, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.
/s/ David Abraham, Attorney-in-Fact for Stephen Smolinski
2017-11-20